Free Trial

Can-Fite BioPharma (CANF) Short Interest Ratio & Short Volume

Can-Fite BioPharma logo
$0.69 -0.01 (-1.29%)
As of 12:48 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Can-Fite BioPharma Short Interest Data

Can-Fite BioPharma (CANF) has a short interest of 93,600 shares. This marks a -29.31% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.8, indicating that it would take 0.8 days of the average trading volume of 213,795 shares to cover all short positions.

Current Short Interest
93,600 shares
Previous Short Interest
132,400 shares
Change Vs. Previous Month
-29.31%
Dollar Volume Sold Short
$97.81 thousand
Short Interest Ratio
0.8 Days to Cover
Last Record Date
July 15, 2025
Outstanding Shares
3,540,000 shares
Percentage of Shares Shorted
2.64%
Today's Trading Volume
35,680 shares
Average Trading Volume
213,795 shares
Today's Volume Vs. Average
17%
Short Selling Can-Fite BioPharma?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Can-Fite BioPharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CANF Short Interest Over Time

CANF Days to Cover Over Time

CANF Percentage of Float Shorted Over Time

Can-Fite BioPharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/202593,600 shares $97.81 thousand -29.3%N/A0.8 $1.05
6/30/2025132,400 shares $139.02 thousand +353.4%3.7%0.6 $1.05
6/15/202529,200 shares $31.24 thousand -62.3%0.8%0.1 $1.07
5/31/202577,500 shares $83.31 thousand -47.2%2.2%0.3 $1.08
5/15/2025146,700 shares $153.30 thousand -52.4%N/A0.5 $1.05
4/30/2025308,000 shares $335.72 thousand -40.0%N/A1.1 $1.09
4/15/2025512,900 shares $646.25 thousand +35.4%N/A1.8 $1.26
3/14/2025204,400 shares $333.17 thousand -20.1%N/A1 $1.63
2/28/2025255,900 shares $450.38 thousand +44.0%N/A0.6 $1.76
2/14/2025177,700 shares $270.99 thousand -23.2%N/A0.4 $1.53
1/31/2025231,400 shares $348.03 thousand -8.9%N/A0.5 $1.50
1/15/2025254,000 shares $403.86 thousand -2.3%N/A0.6 $1.59
6/15/202362,200 shares $194.06 thousand -1.0%N/A1.1 $3.12
5/31/202362,800 shares $162.02 thousand -32.7%N/A1.1 $2.58
5/15/202393,300 shares $0.00 +311.0%N/A1.6 $0.00
4/30/202322,700 shares $0.00 -59.6%N/A0.3 $0.00
4/15/202356,200 shares $0.00 +43.4%N/A0.6 $0.00
3/31/202339,200 shares $89.77 thousand -26.5%N/A0.5 $2.29
3/15/202353,300 shares $0.00 +33.3%N/A0.7 $0.00
2/28/202340,000 shares $0.00 +4.2%N/A0.6 $0.00
2/15/202338,400 shares $0.00 -52.9%N/A0.6 $0.00
1/31/202381,600 shares $0.00 +91.1%N/A1.6 $0.00
1/15/202342,700 shares $0.00 -11.6%N/A1.1 $0.00
12/30/202248,300 shares $0.00 -82.9%N/A3.8 $0.00
12/15/2022282,700 shares $0.00 -19.6%N/A3.8 $0.00
11/30/2022351,500 shares $0.00 -7.5%N/A5.1 $0.00
11/15/2022379,900 shares $0.00 -9.7%N/A4.8 $0.00
10/31/2022420,700 shares $0.00 -5.0%N/A3.5 $0.00
10/15/2022442,900 shares $0.00 -6.9%N/A3.9 $0.00
9/30/2022475,600 shares $0.00 +1.1%N/A3.7 $0.00
9/15/2022470,400 shares $0.00 -7.2%N/A1.1 $0.00
8/31/2022506,600 shares $0.00 -5.9%N/A1.2 $0.00
8/15/2022538,500 shares $0.00 -8.2%N/A1.3 $0.00
7/31/2022586,400 shares $0.00 -10.6%N/A1.5 $0.00
7/15/2022655,700 shares $0.00 +68.5%N/A1.7 $0.00
6/30/2022389,100 shares $357.97 thousand +19.8%N/A1 $0.92
6/15/2022324,800 shares $0.00 -15.7%N/A2.3 $0.00
5/31/2022385,200 shares $0.00 -14.2%N/A2.6 $0.00
5/15/2022448,700 shares $0.00 -6.5%N/A2.2 $0.00
4/30/2022479,700 shares $0.00 -13.9%N/A2.2 $0.00
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the September 1st funding windo
4/15/2022557,000 shares $0.00 -27.7%N/A2.1 $0.00
3/31/2022770,100 shares $0.00 +6.5%N/A2.3 $0.00
3/15/2022722,800 shares $0.00 -11.8%N/A0.2 $0.00
2/28/2022819,200 shares $0.00 +9.2%N/A0.2 $0.00
2/15/2022750,000 shares $0.00 -20.7%N/A0.2 $0.00
1/31/2022946,000 shares $0.00 -19.8%N/A0.2 $0.00
1/15/20221,180,000 shares $0.00 -73.5%N/A0.3 $0.00
12/31/20214,460,000 shares $0.00 +1,231.7%N/A1.2 $0.00
12/15/2021334,900 shares $0.00 -18.8%N/A0.1 $0.00
11/30/2021412,600 shares $0.00 +54.2%N/A1.9 $0.00
11/15/2021267,500 shares $0.00 -15.2%N/A1.3 $0.00
10/29/2021315,400 shares $479.41 thousand +54.3%N/A1.8 $1.52
10/15/2021204,400 shares $0.00 +5.4%N/A1.4 $0.00
9/30/2021193,900 shares $0.00 +25.0%N/A1.3 $0.00
9/15/2021155,100 shares $0.00 -11.5%N/A0.9 $0.00
8/31/2021175,300 shares $0.00 -29.7%N/A0.5 $0.00
8/13/2021249,300 shares $0.00 +10.3%N/A0.7 $0.00
7/30/2021226,100 shares $0.00 -29.8%N/A0.6 $0.00
7/15/2021322,200 shares $0.00 -5.7%N/A0.8 $0.00
6/30/2021341,500 shares $0.00 +0.7%N/A0.9 $0.00
6/15/2021339,300 shares $0.00 +12.9%N/A0.8 $0.00
5/28/2021300,500 shares $0.00 -35.4%N/A0.1 $0.00
5/14/2021465,300 shares $0.00 -14.2%N/A0.1 $0.00
4/30/2021542,400 shares $0.00 -23.7%N/A0.1 $0.00
4/15/2021711,200 shares $1.51 million -20.6%N/A0.2 $2.12
3/31/2021895,200 shares $2.03 million +187.5%N/A0.2 $2.27
3/15/2021311,400 shares $716.22 thousand -7.2%N/A0.1 $2.30
2/26/2021335,700 shares $772.11 thousand -37.5%N/A0.3 $2.30
2/12/2021537,200 shares $1.04 million +56.1%N/A0.5 $1.93
1/29/2021344,100 shares $812.08 thousand +23.3%N/A0.5 $2.36
1/15/2021279,000 shares $669.60 thousand -3.8%N/A0.6 $2.40
12/31/2020289,900 shares $530.52 thousand +13.5%N/A0.6 $1.83
12/15/2020255,400 shares $503.14 thousand -14.9%N/A0.6 $1.97
11/30/2020300,000 shares $564 thousand -13.1%N/A0.8 $1.88
11/15/2020345,200 shares $626.54 thousand +0.5%N/A0.9 $1.82
10/30/2020343,600 shares $601.30 thousand +4.9%N/A0.7 $1.75
10/15/2020327,600 shares $668.30 thousand -1.7%N/A0.5 $2.04
9/30/2020333,100 shares $589.59 thousand +0.3%N/A0.3 $1.77
9/15/2020332,100 shares $627.67 thousand -13.3%N/A0.2 $1.89
8/31/2020382,900 shares $853.87 thousand -12.3%N/A0.2 $2.23
8/14/2020436,800 shares $1.02 million -10.9%N/A0.3 $2.33

CANF Short Interest - Frequently Asked Questions

What is Can-Fite BioPharma's current short interest?

Short interest is the volume of Can-Fite BioPharma shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 93,600 shares of CANF short. Learn More on Can-Fite BioPharma's current short interest.

What is a good short interest ratio for Can-Fite BioPharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CANF shares currently have a short interest ratio of 1.0. Learn More on Can-Fite BioPharma's short interest ratio.

Is Can-Fite BioPharma's short interest increasing or decreasing?

Can-Fite BioPharma saw a drop in short interest during the month of July. As of July 15th, there was short interest totaling 93,600 shares, a drop of 29.3% from the previous total of 132,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Can-Fite BioPharma's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Can-Fite BioPharma: Acurx Pharmaceuticals, Inc. (2.48%), X4 Pharmaceuticals, Inc. (10.17%), Aprea Therapeutics, Inc. (1.31%), Soligenix Inc. (8.91%), Sonnet BioTherapeutics Holdings, Inc. (18.42%), Chromocell Therapeutics Co. (8.70%), Addex Therapeutics Ltd. Sponsored ADR (0.15%), Cellectar Biosciences, Inc. (2.58%), Cyclerion Therapeutics, Inc. (0.89%), Synaptogenix, Inc. (12.63%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks.

What does it mean to sell short Can-Fite BioPharma stock?

Short selling CANF is an investing strategy that aims to generate trading profit from Can-Fite BioPharma as its price is falling. CANF shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Can-Fite BioPharma?

A short squeeze for Can-Fite BioPharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CANF, which in turn drives the price of the stock up even further.

How often is Can-Fite BioPharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CANF, twice per month. The most recent reporting period available is July, 15 2025.




This page (NYSE:CANF) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners